focus -WSS

focus

author：fashion 2025-09-27 19:49:32 - browse：4

Coronary medical stent -- health business coverage from STAT — Adobe

Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs the health system millions and unnecessarily exposes patients to risks of blood clots, torn arteries, infections, and other life-threatening injuries.

In 2020, Medicare started paying physicians to place stents, balloons, and perform other procedures designed to open clogged coronary arteries outside of hospitals, in less expensive outpatient settings. It didn’t take long for private equity firms to catch on. They’ve been racing to buy up cardiology practices ever since, rolling them into bigger and bigger chains with an eye toward reselling them at a profit.

It’s similar to what happened with orthopedics and gastroenterology, two specialties that have become saturated with private equity money since more procedures went outpatient. Research in other specialties has shown that these financial investors tend to usher in more patients, ramp up surgeries, and jack up prices, effectively increasing spending even as government policies try to lower it. Now, experts say they fear the same thing could happen in cardiology, a field with a long track record of overuse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Amylyx's ALS drug launch starts strong. It could be trouble for FDA

WSS

Drastic changes should bring profitability, startup health insurers say

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

A biotech analyst on neuroscience, placebo effect, not over

Asbestos ban is immediate, but health effects will linger for decades

Chinese researcher claims birth of first gene

Friends ask where James Watson's attitudes about race came from

knowledge

focus

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

With Wegovy coverage, Medicare patients may face high costs

Hepatitis C has a cure — but many Americans still lack access to it

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

23andMe had bad news about my health. I wish a person had delivered it

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Wildfire smoke exposes gaps in outdoor worker protections

The best solution to the drug shortages problem

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

focus

Wegovy’s successful heart trial raises vital question about weight loss

NIH trials fail to test meaningful long Covid therapies, experts say

What Kate Middleton's cancer revelation might teach the world

How to use technology to prevent future drug shortages

U.K. officials, researchers try to ease path for bespoke genetic treatments

What to know about Virgin Galactic's 1st mission taking paying customers to space

hotspot

Wikipedia

entertainment

focus